局部介入给药治疗结构性胸膜炎的疗效观察

• 作 者: 黄月莲 孙琳 杨改萍
• 出 处: 西山科技
• 发表日期: 2000年04期
• 关键词: 结核性胸膜炎 雷米封 地塞米松 结核 抗痨治疗 胸膜炎 胸腔内注药 胸膜 胸腔 治疗结果

目的：确定地塞米松在治疗结核性渗出性胸腔炎的作用。方法：在规则抗痨治疗下，对 ３８例结核性胸膜炎的病人胸腔内注入地塞米松 ５ ｍｇ十雷米封 ０． ２ ｇ／ｄ～０． ３ ｇ／ｄ。 ３５例不作胸腔内注药对照。结果：治疗组３８例中，９４．７％胸水完全吸收，对照组３５例中，７４．３％胸水完全吸收。结论：在规则抗痨治疗下配合胸腔内注入地塞米松、雷米封治疗结核性胸膜炎可防止胞膜肥厚，并改善肺功能。

Objective: To determine the role of dexamethasone in the treatment of tuberculous exudative pleural inflammation. Methods: Thirty-eight patients with tuberculous pleurisy were injected intrathoracially with 5 mg of dexamethasone 5 mg / 2 g / d ~ 0. 3 g / d. Thirty-five patients did not receive intrathoracic injection. Results: In the treatment group, 94.7% pleural effusion was completely absorbed, while in the control group, 74.3% pleural effusion was completely absorbed. CONCLUSIONS: In combination with intrathoracic injection of dexamethasone and regimen in the treatment of tuberculosis pleurisy under regular anti-tuberculosis therapy, membrane hypertrophy is prevented and pulmonary function is improved.